Gene Page: DNASE1L2
Summary ?
GeneID | 1775 |
Symbol | DNASE1L2 |
Synonyms | DNAS1L2 |
Description | deoxyribonuclease I-like 2 |
Reference | MIM:602622|HGNC:HGNC:2958|Ensembl:ENSG00000167968|HPRD:04018|Vega:OTTHUMG00000177086 |
Gene type | protein-coding |
Map location | 16p13.3 |
Pascal p-value | 0.436 |
Fetal beta | 0.255 |
eGene | Myers' cis & trans |
Support | CompositeSet |
Gene in Data Sources
Gene set name | Method of gene set | Description | Info |
---|---|---|---|
DNM:Fromer_2014 | Whole Exome Sequencing analysis | This study reported a WES study of 623 schizophrenia trios, reporting DNMs using genomic DNA. |
Section I. Genetics and epigenetics annotation
DNM table
Gene | Chromosome | Position | Ref | Alt | Transcript | AA change | Mutation type | Sift | CG46 | Trait | Study |
---|---|---|---|---|---|---|---|---|---|---|---|
DNASE1L2 | chr16 | 2287532 | C | T | NM_001374 | p.158P>L | missense | Schizophrenia | DNM:Fromer_2014 |
eQTL annotation
SNP ID | Chromosome | Position | eGene | Gene Entrez ID | pvalue | qvalue | TSS distance | eQTL type |
---|---|---|---|---|---|---|---|---|
snp_a-2054853 | 0 | DNASE1L2 | 1775 | 0.1 | trans | |||
rs10026915 | chr4 | 57857770 | DNASE1L2 | 1775 | 0.04 | trans |
Section II. Transcriptome annotation
General gene expression (GTEx)
Gene expression during devlopment (BrainCloud)
Footnote:
A total of 269 time points ploted, with n=38 fetal samples (x=1:38). Each triangle represents one time point.
Gene expression of temporal and spatial changes (BrainSpan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
Top co-expressed genes in brain regions
Top 10 positively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
ZNF649 | 0.89 | 0.84 |
RBBP4 | 0.88 | 0.85 |
BBS9 | 0.87 | 0.86 |
MCPH1 | 0.87 | 0.85 |
ERCC8 | 0.87 | 0.86 |
XRCC5 | 0.86 | 0.85 |
G2E3 | 0.86 | 0.86 |
INTS7 | 0.86 | 0.84 |
PRPF40A | 0.86 | 0.85 |
PHF16 | 0.86 | 0.80 |
Top 10 negatively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
PTH1R | -0.59 | -0.68 |
SLC9A3R2 | -0.58 | -0.57 |
AF347015.27 | -0.57 | -0.73 |
HLA-F | -0.57 | -0.66 |
TNFSF12 | -0.57 | -0.61 |
MT-CO2 | -0.57 | -0.75 |
AF347015.31 | -0.57 | -0.74 |
AF347015.33 | -0.56 | -0.73 |
AIFM3 | -0.56 | -0.65 |
C5orf53 | -0.56 | -0.61 |
Section V. Pathway annotation
Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
---|---|---|---|
ENK UV RESPONSE EPIDERMIS DN | 508 | 354 | All SZGR 2.0 genes in this pathway |
PEREZ TP53 TARGETS | 1174 | 695 | All SZGR 2.0 genes in this pathway |
SCHAEFFER PROSTATE DEVELOPMENT 48HR UP | 487 | 286 | All SZGR 2.0 genes in this pathway |
STONER ESOPHAGEAL CARCINOGENESIS UP | 39 | 25 | All SZGR 2.0 genes in this pathway |
BANDRES RESPONSE TO CARMUSTIN MGMT 48HR DN | 161 | 105 | All SZGR 2.0 genes in this pathway |
BONOME OVARIAN CANCER SURVIVAL SUBOPTIMAL DEBULKING | 510 | 309 | All SZGR 2.0 genes in this pathway |
QI PLASMACYTOMA UP | 259 | 185 | All SZGR 2.0 genes in this pathway |
BYSTRYKH HEMATOPOIESIS STEM CELL SCP2 QTL TRANS | 25 | 13 | All SZGR 2.0 genes in this pathway |
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 15 | 35 | 23 | All SZGR 2.0 genes in this pathway |
MARTENS TRETINOIN RESPONSE DN | 841 | 431 | All SZGR 2.0 genes in this pathway |